Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.38 | 14.00 |
| PEG Ratio (TTM) | -0.45 | -4.91 |
| P/S Ratio (TTM) | 0.20 | 0.33 |
| P/B Ratio (TTM) | 0.93 | 1.56 |
| P/FCF Ratio (TTM) | 7.02 | 10.56 |
| Price to 5YR AVG Earnings Ratio | 11.73 | 17.28 |
| Price to 5YR AVG FCF Ratio | -1,453.32 | 15.72 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.77% | 2.98% |
| ROE (TTM) | 6.98% | 9.72% |
| Net Profit Margin (TTM) | 1.51% | 1.85% |
| ROIC 5YR AVG | 11.09% | 12.80% |
Growth (48%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -25.32% | 304.80% | 179.89% |
| Revenue | -2.95% | 8.52% | 4.85% |
| Net Income | -25.99% | 298.56% | 174.34% |
| Cash Flow | 293.06% | -130.71% | -84.18% |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.25 | 1.60 |
| Quick Ratio (TTM) | 1.07 | 1.09 |
| D/E Ratio (TTM) | 0.60 | 0.55 |
| Interest Coverage (TTM) | 2.80 | 8.04 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 3.34 | 2.94 |
| LTL to 5YR AVG FCF | -815.12 | -117.25 |
| Shares Outstanding Growth 5YR AVG | -3.73% | 4.61% |